FDA approves second generic mifepristone, drawing criticism from anti-abortion groups despite the drug's long safety record.
White House ties federal research funds to universities' compliance with a controversial 10-point compact that restricts academic freedom and diversity policies.
Philadelphia leaders develop 5-year public safety plan with community input to build trust and improve policing.
FDA approves second generic mifepristone, drawing criticism from anti-abortion groups despite the drug's long safety record.
White House ties federal research funds to universities' compliance with a controversial 10-point compact that restricts academic freedom and diversity policies.
Philadelphia leaders develop 5-year public safety plan with community input to build trust and improve policing.